Company Details

Merganser Biotech
Overview
Develops medicines for hematological and iron overload diseases.
Total Raised
$28 M
Rounds
2
Links
Verticals
Biotechnology
Health Care
Therapeutics
Investment History
Series A
Feb 2015
$28M

Develops medicines for hematological and iron overload diseases.
Total Raised
$28 M
Rounds
2
Links
Verticals
Series A
Feb 2015
$28M